TY - JOUR
T1 - Predictive value of mechanomyography and accelerometry for pulmonary function in partially paralyzed volunteers
AU - Eikermann, Matthias
AU - Groeben, H.
AU - Hüsing, J.
AU - Peters, J.
PY - 2004/3
Y1 - 2004/3
N2 - Background: Accelerometry (ACM) of adductor pollicis muscle has been used for monitoring of neuromuscular blockade but its validity compared with the gold standard, mechanomyography (MMG), has been questioned. During neuromuscular blockade we compared these methods and we assessed pulmonary function. Methods: In awake partially paralyzed volunteers we spirometrically assessed pulmonary function every 5 min until recovery. Rocuronium (0.01 mg kg-1 + 2-10 μg kg-1 min-1) was administered to maintain train-of-four (TOF)-ratios (assessed every 15 s) of approximately 0.5 and 0.8 over a period of more than 5 min. The TOF-ratio associated with 'acceptable' pulmonary recovery [forced vital capacity (FVC) and forced inspiratory volume in 1 s (FIV1) of ≥90% of baseline] was calculated using a linear regression model. During 5-min periods of repetitive nerve stimulation we compared the squared residuals of the FVC and FIV 1 estimates from TOFACM vs. TOFMMG, and compared variance of values derived from ACM and MMG using Wilcoxon's test. Results: Limits of agreement of TOF-ratio derived from ACM and MMG were wide [0.15 ± 0.016 (SD)], and variability of TOFACM exceeded that of TOFMMG [variance: 77 ± 105, vs. 51 ± 55% (P < 0.01)]. Calculated TOFACM and TOFMMG ratios of 0.56 (0.22-0.71) [mean (95%CI) and 0.6 (0.28-0.74)], respectively, predict 'acceptable' (90%) recovery of FVC while FIV1 remains impaired until TOF-ratios of 0.91 (0.82-1.07) and 0.95 (0.82-1.18), respectively. In turn, TOFMMG (TOFACM) of unity predicted 'acceptable' recovery of FVC and FIV1 in 94 (93) % and 68 (73) % of measurements, respectively. Conclusions: Accelerometry predicts effects of relaxation on pulmonary function as valid as the gold standard mechanomyography. We recommend that recovery of TOF ratio to 0.9-1.0 should be used as an indication of sufficient neuromuscular recovery in daily practice.
AB - Background: Accelerometry (ACM) of adductor pollicis muscle has been used for monitoring of neuromuscular blockade but its validity compared with the gold standard, mechanomyography (MMG), has been questioned. During neuromuscular blockade we compared these methods and we assessed pulmonary function. Methods: In awake partially paralyzed volunteers we spirometrically assessed pulmonary function every 5 min until recovery. Rocuronium (0.01 mg kg-1 + 2-10 μg kg-1 min-1) was administered to maintain train-of-four (TOF)-ratios (assessed every 15 s) of approximately 0.5 and 0.8 over a period of more than 5 min. The TOF-ratio associated with 'acceptable' pulmonary recovery [forced vital capacity (FVC) and forced inspiratory volume in 1 s (FIV1) of ≥90% of baseline] was calculated using a linear regression model. During 5-min periods of repetitive nerve stimulation we compared the squared residuals of the FVC and FIV 1 estimates from TOFACM vs. TOFMMG, and compared variance of values derived from ACM and MMG using Wilcoxon's test. Results: Limits of agreement of TOF-ratio derived from ACM and MMG were wide [0.15 ± 0.016 (SD)], and variability of TOFACM exceeded that of TOFMMG [variance: 77 ± 105, vs. 51 ± 55% (P < 0.01)]. Calculated TOFACM and TOFMMG ratios of 0.56 (0.22-0.71) [mean (95%CI) and 0.6 (0.28-0.74)], respectively, predict 'acceptable' (90%) recovery of FVC while FIV1 remains impaired until TOF-ratios of 0.91 (0.82-1.07) and 0.95 (0.82-1.18), respectively. In turn, TOFMMG (TOFACM) of unity predicted 'acceptable' recovery of FVC and FIV1 in 94 (93) % and 68 (73) % of measurements, respectively. Conclusions: Accelerometry predicts effects of relaxation on pulmonary function as valid as the gold standard mechanomyography. We recommend that recovery of TOF ratio to 0.9-1.0 should be used as an indication of sufficient neuromuscular recovery in daily practice.
KW - Accelerometry
KW - Mechanomyography
KW - Neuromuscular monitoring
UR - http://www.scopus.com/inward/record.url?scp=1542286577&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1542286577&partnerID=8YFLogxK
U2 - 10.1111/j.0001-5172.2004.0326.x
DO - 10.1111/j.0001-5172.2004.0326.x
M3 - Article
C2 - 14982572
AN - SCOPUS:1542286577
SN - 0001-5172
VL - 48
SP - 365
EP - 370
JO - Acta Anaesthesiologica Scandinavica
JF - Acta Anaesthesiologica Scandinavica
IS - 3
ER -